To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Category: EBCI App

March 16, 2023
EBCI APP - Stay Up to Date Faster on Brain Cancer Treatments

The new EBCI app is the fastest way to learn of new treatment options, trials, events, webinars, research updates, and so much more!

Read More
November 17, 2022
End Brain Cancer Mobile App Is Here!

To advance our mission of education and advocacy, we have developed a mobile app where you can find information and interact with the Brain Tumor Community. Download the app today.

Read More
July 20, 2022
July 20th is National GBM Awareness Day

Your support is essential to ensuring that the unmet needs of the brain tumor community continue to be heard and addressed. Together, we can advocate for patients and families today, while fueling research with the potential to become the treatments and cures of tomorrow.

Read More
June 3, 2022
Join us at ASCO 2022 June 3rd - 7th - Booth #3005

The ASCO Annual Meeting is for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide. You can Instantly access the top oncology research from ASCO meetings—including abstracts, videos, posters, and slides. EBCI will, once again, be attending this amazing event.

Read More
April 9, 2022
20th Year Anniversary Milestone: Announcing EBCI’s Disease Education, Awareness & Outreach

It is unbelievable that the Chris Elliott Fund DBA End Brain Cancer Initiative (EBCI) is turning 20 years old THIS year!

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram